|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,089,697 |
|
Indirect Shares
|
264,473 |
|
|
Direct
Value |
$8,309,557 |
|
|
Indirect Value
|
$120,004 |
|
|
Total
Shares |
1,354,170 |
|
|
Total
Value |
$8,429,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
372 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
Director |
|
2016-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,055 |
113,892 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
104,325 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-06-21 |
4 |
B |
$2.00 |
$100,000 |
D/D |
50,000 |
430,724 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2016-06-24 |
4 |
B |
$3.70 |
$184,845 |
D/D |
50,000 |
381,440 |
2.39 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
733 |
105,058 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2016-08-18 |
4 |
B |
$0.99 |
$24,750 |
D/D |
25,000 |
1,763,637 |
3.92 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-09-13 |
4 |
B |
$0.79 |
$79,180 |
D/D |
100,000 |
530,724 |
2.39 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-09-23 |
4 |
S |
$109.42 |
$1,641,300 |
D/D |
(15,000) |
90,058 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2016-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
1,779,262 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
630,724 |
2.31 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-11-23 |
4 |
B |
$0.41 |
$48,600 |
I/I |
120,000 |
120,000 |
2.1 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2016-12-27 |
4 |
AS |
$4.65 |
$354,050 |
I/I |
(75,709) |
292,826 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2016-12-28 |
4 |
AS |
$4.52 |
$110,317 |
I/I |
(24,291) |
268,535 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-01-23 |
4 |
A |
$0.90 |
$15,000 |
D/D |
16,667 |
1,795,929 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-02-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,570 |
86,488 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
63,822 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-02-27 |
4 |
S |
$121.24 |
$1,454,880 |
D/D |
(12,000) |
57,424 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-04-07 |
4 |
A |
$0.63 |
$15,000 |
D/D |
23,809 |
1,819,738 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
64,572 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
86,863 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
87,196 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-06-30 |
4 |
S |
$4.28 |
$26,117 |
I/I |
(6,105) |
5,895 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
734 |
87,930 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-07-16 |
4 |
A |
$0.61 |
$15,000 |
D/D |
24,590 |
1,844,328 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-08-10 |
4 |
S |
$130.52 |
$2,415,403 |
D/D |
(18,506) |
69,424 |
0 |
- |
|
372 Records found
|
|
Page 12 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|